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Research
AbstrACt
Objective To investigate the epidemiology of medication 
errors and error-related adverse events in adults in 
primary care, ambulatory care and patients’ homes.
Design Systematic review.
Data source Six international databases were searched 
for publications between 1 January 2006 and 31 
December 2015.
Data extraction and analysis Two researchers 
independently extracted data from eligible studies 
and assessed the quality of these using established 
instruments. Synthesis of data was informed by an 
appreciation of the medicines’ management process 
and the conceptual framework from the International 
Classification for Patient Safety.
results 60 studies met the inclusion criteria, of which 53 
studies focused on medication errors, 3 on error-related 
adverse events and 4 on risk factors only. The prevalence 
of prescribing errors was reported in 46 studies: 
prevalence estimates ranged widely from 2% to 94%. 
Inappropriate prescribing was the most common type of 
error reported. Only one study reported the prevalence 
of monitoring errors, finding that incomplete therapeutic/
safety laboratory-test monitoring occurred in 73% of 
patients. The incidence of preventable adverse drug 
events (ADEs) was estimated as 15/1000 person-years, 
the prevalence of drug–drug interaction-related adverse 
drug reactions as 7% and the prevalence of preventable 
ADE as 0.4%. A number of patient, healthcare professional 
and medication-related risk factors were identified, 
including the number of medications used by the patient, 
increased patient age, the number of comorbidities, use 
of anticoagulants, cases where more than one physician 
was involved in patients’ care and care being provided by 
family physicians/general practitioners.
Conclusion A very wide variation in the medication error 
and error-related adverse events rates is reported in the 
studies, this reflecting heterogeneity in the populations 
studied, study designs employed and outcomes evaluated. 
This review has identified important limitations and 
discrepancies in the methodologies used and gaps in the 
literature on the epidemiology and outcomes of medication 
errors in community settings.
IntrODuCtIOn 
Patient safety is a public concern in health-
care systems across the world.1 Medication 
errors and error-related adverse drug events 
(ADEs) are common and are responsible for 
considerable patient harm.1 More specifically, 
strengths and limitations of this study
 ► This is the first systematic review on the epidemi-
ology of medication errors and medication-asso-
ciated harm in community settings. The use of the 
International Classification for Patient Safety con-
ceptual framework helped with framing and organ-
ising the findings from this systematic review.
 ► A rigorous and transparent process has been em-
ployed, which included no language restrictions in 
undertaking searches, independent screening of 
titles, abstracts and full-text papers, independent 
data extraction, and critical appraisal of included 
studies by two reviewers.
 ► Outcomes have been reported in a variety of ways 
using different tools and methodology, which made 
it difficult to undertake any quantitative pooled sum-
mary of the results.
 ► Despite the comprehensiveness of the searches, we 
found no data regarding errors during medication 
dispensing and administration. This might be due to 
the lack of ‘dispensing error’ and ‘administration er-
ror’ terms in our search strategy, although ‘medica-
tion therapy management’ was included as a more 
overarching search term.
 ► There is at present no agreed, consistently applied 
set of confounders that should be taken into account 
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ADEs can lead to morbidity, hospitalisation, increased 
healthcare costs and, in some cases, death.1 It has been 
estimated that 5%–6% of all hospitalisations are drug-re-
lated,2 3 with one estimate suggesting that ADEs causing 
hospital admission in the UK occur in around 10% of 
inpatients; approximately half of these ADEs are believed 
to be preventable.4 The cost of medication errors world-
wide has been estimated as US$42 billion/year.5
Since the release of To Err is Human: Building a Safer 
Health System by the Institute of Medicine (now the 
National Academy of Medicine),6 which focused on 
acute care settings, most patient safety research has been 
conducted in hospital settings.7 8 Given that interna-
tional and national policy drivers are for patients to be 
increasingly managed in primary, ambulatory and home 
settings in order to realise the goals of more accessible, 
patient-centred and efficient healthcare,9 there is an 
increased sense of urgency to further focus attention 
on community care contexts, particularly in relation to 
medication safety. With an ageing population, particu-
larly in economically developed countries, as well as the 
use of polypharmacy, there is a need to empower patients, 
particularly those with chronic diseases, to self-care safely.
The aim of this systematic review was to investigate the 
epidemiology of medication errors, error-related adverse 
events and risk factors for errors in adults managed in 
community care contexts (ie, primary care, ambulatory 
and home settings). Box 1 provides definitions of the key 
terms employed in this review.
MethODs
Protocol and reporting
The study protocol was developed following the Preferred 
Reporting Items for Systematic Reviews and Meta-Anal-
yses (PRISMA) guidelines, and was registered in PROS-
PERO.10 11 The detailed systematic review protocol has 
also been published.12
eligibility criteria/study selection
Studies conducted in adults (≥18 years) who were looked 
after in the community and living in their own or family 
homes without home healthcare or nursing home were 
eligible for inclusion in this review. The studied patients 
could have been self-managing, receiving care in primary 
care or ambulatory care settings, or any combination 
of the above. Studies were included if they were popu-
lation-based, cross-sectional or cohort studies, which 
were suitable to estimate the incidence and prevalence 
of medication errors or ADEs. These study designs and 
case–control studies were considered eligible to study 
risk factors for the development of error-related ADEs. 
Studies with prescribed and/or over-the-counter (OTC) 
medications as the exposure of interest were eligible.
Paediatric studies (<18 years) and studies on patients 
receiving care in hospital at home settings (ie, contin-
uous medical and/or nursing care provided to patients in 
their own homes), in nursing homes, as hospitalised inpa-
tients or in emergency departments (ED) were excluded. 
Randomised controlled trials were excluded since these 
could not be used to reliably assess the incidence and/or 
prevalence of the outcomes of interest. Existing reviews 
were also excluded since the focus was on the primary 
literature. Incompletely reported studies, for example, 
in the form of abstracts, were not eligible for inclusion. 
Studies on illegal substance abuse, herbal products 
and those focusing on particular medications were also 
excluded.
No restriction on the language of publication was 
employed.
Data sources and search strategy
Search terms were developed based on the system-
atic review protocol.12 The search terms and detailed 
search strategies are presented in online supplemen-
tary appendix 1. In summary, these involved identi-
fying search terms (and their synonyms) in relation 
to medication safety, community care settings and 
study design, and combining these concepts with the 
Boolean operator AND to identify studies that inter-
sected all three search concepts of interest. Exam-
ples of the search terms used included the following: 
for the outcome: medication safety, medication error, 
preventable adverse drug event and patient error; 
for the setting: ambulatory care, outpatient, self-care, 
primary healthcare and general practice; and for the 
study design: cohort study, cross sectional study and 
observational study. Six biomedical databases were 
searched, including the Cumulative Index to Nursing 
box 1 Key definitions
 ► Adverse drug event (ADE): Bates et al84 define ADE as ‘an injury 
resulting from medical intervention related to a drug’.84 Some ADEs 
are caused by underlying medication errors and therefore they are 
preventable.
 ► Medication error: The National Coordinating Council for Medication 
Error Reporting and Prevention defines a medication error as ‘any 
preventable event that may cause or lead to inappropriate medi-
cation use or patient harm, while the medication is in the control 
of the health care professional, patient, or consumer. Such events 
may be related to professional practice, health care products, pro-
cedures, and systems, including prescribing; order communication; 
product labelling, packaging, and nomenclature; compounding; 
dispensing; distribution; administration; education; monitoring; 
and use’.85 Medication errors can result from any step of the med-
ication-use process: selection and procurement, storage, order-
ing and transcribing, preparing and dispensing, administration, or 
monitoring.1
 ► Non-prescription drugs: Medicines that can be sold legally without 
a drug prescription.
 ► Over-the-counter (OTC) drug: The Food and Drug Administration 
defines OTC drugs as ‘drugs that have been found to be safe and 
appropriate for use without the supervision of a health care profes-
sional such as a physician, and they can be purchased by consum-
ers without a prescription’.86
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and Allied Health Literature, EMBASE, Eastern Medi-
terranean Regional Office of the WHO, MEDLINE, 
PsycINFO and Web of Science, between 1 January 2006 
and 31 December 2015. Google Scholar was searched 
for additional studies. An international panel of experts 
was also contacted to identify unpublished work and 
research in progress (online supplementary appendix 
1). The reference list of all included studies was further 
reviewed for additional possible eligible studies.
The databases were searched by GAA. The title and 
abstracts were then independently screened for eligible 
studies according to the above detailed selection 
criteria by GAA and a second reviewer, NAS. The corre-
sponding authors of the eligible articles were contacted 
if additional information was needed. Disagreements 
were resolved by discussion between the reviewers or by 
arbitration by a third reviewer, AS, if a decision could 
not be reached. Full-text articles were retrieved from 
selected studies and reviewed according to the selection 
criteria. Each copy of the selected studies was retrieved 
and the reason for excluding other studies was clearly 
noted.
Data extraction and risk of bias assessment
Data were independently extracted and recorded onto a 
customised data extraction sheet by two reviewers (GAA 
and NAS, or GAA and MAM). Discrepancies were resolved 
by discussion or by arbitration by an additional reviewer 
(AS), if necessary.
Key information, such as study design, study type (retro-
spective, prospective), population of interest, exposure 
of interest, outcomes of interest and main findings, was 
extracted.
The risk of bias assessment was independently carried 
out on each study by two reviewers (GAA and NAS, 
or GAA and NA) using the Critical Appraisal Skills 
Programme (CASP) quality assessment tool for cohort 
and case–control studies,13 and cross-sectional studies 
were assessed using the Joanna Briggs Institute (JBI) 
Critical Appraisal Checklist for descriptive studies.14 Any 
disagreements were resolved by consensus or by arbitra-
tion by a third reviewer (AS) if a decision could not be 
reached. Each study was given an overall grading as being 
at high, medium or low risk of bias.
Data synthesis
Data were summarised in detailed data tables, which 
included information on the incidence, prevalence, rela-
tive risk and ORs, together with 95% CIs, for each study 
(where available). A descriptive and narrative synthesis of 
the extracted data was undertaken.
The following is the definition of incidence rate used in 
this review: ‘the number of patients with one or more [medica-
tion error or preventable ADE] (numerator) divided by the total 
number of patients at risk per time unit (denominator)’.15 The 
following is the definition of prevalence rate used in the 
data extraction: ‘the number of patients experiencing one or 
more [medication error or preventable ADE] (numerator) divided 
by the total number of patients in the study population (denom-
inator)’.16 The prevalence rate per population was either 
reported and extracted directly from the included study 
or calculated from data provided in the study.
We worked with the definitions of medication errors and 
error-related ADEs employed in individual studies. These 
errors may have occurred anywhere in the medicines’ 
management process.1 Medication errors were described 
according to (1) the stage in the medicines’ management 
process when the error occurred, that is, prescribing, 
dispensing, administration and monitoring1; and (2) the 
type of error that occurred in each stage according to the 
conceptual framework for the International Classification 
for Patient Safety (ICPS) definitions (box 2).17
Risk factors were categorised as patient, healthcare 
professional and medication-related risk factors.
box 2 Classification of definitions used in this systematic 
review
 ► Administration error: ‘Any discrepancy between how the medication 
is given to the patient and the administration directions from the 
physician or hospital guidelines’.1
 ► Prescribing error: ‘Medication error occurring during the prescrip-
tion of a medicine that is about writing the drug order or taking the 
therapeutic decision, appreciated by any non-intentional deviation 
from standard reference such as: the actual scientific knowledge, 
the appropriate practices usually recognized, the summary of the 
characteristics of the medicine product, or the mentions accord-
ing to the regulations. A prescribing error notably can concern: the 
choice of the drug (according to the indications, the contraindica-
tions, the known allergies and patient characteristics, interactions 
whatever nature it is with the existing therapeutics, and the other 
factors), dose, concentration, drug regimen, pharmaceutical form, 
route of administration, duration of treatment, and instructions of 
use; but also the failure to prescribe a drug needed to treat an al-
ready diagnosed pathology, or to prevent the adverse effects of oth-
er drugs’.17
 ► Inappropriate prescribing:  ‘The use of medicines that introduce a 
significant risk of an adverse drug-related event where there is ev-
idence for an equally or more effective but lower-risk alternative 
therapy available for treating the same condition. Inappropriate pre-
scribing also includes the use of medicines at a higher frequency 
and for longer than clinically indicated, the use of multiple medicines 
that have recognized drug–drug interactions and drug–disease in-
teractions, and importantly, the under-use of beneficial medicines 
that are clinically indicated but not prescribed for ageist or irrational 
reasons’.87
 ► Monitoring error: ‘Failure to review a prescribed regimen for appro-
priateness and detection of problems, or failure to use appropriate 
clinical or laboratory data for adequate assessment of patient re-
sponse to prescribed theory’.17
 ► Dispensing error:  ‘Deviation from the prescriber’s order, made by 
staff in the pharmacy when distributing medications to nursing units 
or to patients in an ambulatory pharmacy setting’.17
 ► Other discrepancies:‘Any differences between the medication de-
scribed by the patient and caregivers with the drugs listed by their 
general practitioners (GP) or between the medications listed in the 
discharge letter for the primary care physician with those in the 
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Changes from the original protocol
The following changes were made from the plans 
described in the research protocol12: (1) due to the large 
quantity of studies found during the initial search and 
because of medications and practice changes over the 
years, only studies published in the last 10 years were 
included: 1 January 2006–31 December 2015; (2) only 
studies with the incidence or prevalence rate per number 
of patients were included; and (3) meta-analysis was not 
possible due to the heterogeneity of outcomes, methods 
and definitions.
results
A total of 13 033 potentially eligible studies were iden-
tified after removing duplicates, of which 59 studies 
met the inclusion criteria. One additional study was 
identified through hand-searching. Therefore, a total 
Figure 1 PRISMA flow diagram (from Moher et al88). CINAHL, Cumulative Index to Nursing and Allied Health Literature; EMRO, 
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of 60 studies were included in the systematic review 
(figure 1).
One study was available only in German and one in 
Spanish. Those two papers were retrieved and translated 
into English by native speakers.18 19
The key characteristics of all included studies are 
presented in table 1. The quality assessments of these 
studies are summarised in tables 2A and 2B.
Nine studies were conducted in Asia, 4 in Australia, 32 
in Europe, 8 in North America, 5 in South America and 
2 were conducted across continents (one study covering 
two Australian countries, three European countries, 
one North American country and one South American 
country,20 and one study across two Australian countries, 
four European countries, one North American country 
and one South American country).21 Nineteen studies 
were conducted in primary healthcare or general prac-
tice contexts, 15 studies in home or community settings, 
16 studies in ambulatory care or outpatient settings, 5 
studies in community pharmacies and 2 studies in post-
discharge settings, while 3 studies used secondary data 
analysis.
Eleven studies enrolled adults in all age groups (>18 
years), three studies reported the mean age only,22–24 one 
enrolled those 55 years or older,25 five enrolled those 
aged 60 years or older,26–30 and the majority of studies 
(n=40 studies, 67%) enrolled patients 65 years or older. 
If the study included adult and paediatric data, only rele-
vant adult data were extracted.
The quality of the cross-sectional or descriptive studies 
using the JBI Critical Appraisal Checklist was high for nine 
studies, moderate for ten studies and low for one study. 
The quality of the cohort studies using the CASP quality 
assessment tool was high for 37 studies and moderate for 
3 studies.
Different methods of medication errors and error-re-
lated adverse events identification were used in the 
studies, including data review (electronic/paper-based 
medical record review, lab review, prescription review), 
database analysis, patient survey (face-to-face or tele-
phone interview and survey or questionnaire), patient 
self-report and home visits.
MeDICAtIOn errOrs
Incidence and/or prevalence
We found no study reporting data on the incidence 
of medication errors. Estimates of community setting 
medication error prevalence were available from 53 
studies.18–21 23 24 26 27 29–73
Self-reported medication errors
The period prevalence of self-reported medication errors 
was measured in four cross-sectional studies by Adams et al, 
Lu and Roughead, Sears et al21 and Mira et al.20 21 72 73 In 
the first three studies, the period prevalence was reported 
as 2%, 6% and 6%, respectively,20 21 72 while in Mira et al’s 
study 75% of elderly patients with multiple comorbidities 
and polypharmacy (five or more drugs) reported having 
made at least one mistake with their medication 
(including errors related to dose, similar appearance of 
medications and lack of understanding of the physician’s 
instructions).73 In this study, in 5% of cases, errors due to 
drug confusion had very severe consequences, requiring 
a visit to the emergency services or hospital admission.73 
That wide differences in prevalence were seen between 
the first three studies and the last may be due to popula-
tion factors. Mira et al’s study population comprised older 
polymedicated patients with multiple comorbidities. This 
elderly group had a greater risk of error, while the first 
three studies had populations including any patient over 
18 years.
MeDICAtIOn errOr ACCOrDIng tO MeDICInes’ 
MAnAgeMent PrOCess
Prescribing errors
The point or period prevalence of prescribing errors was 
reported in 46 studies. In these studies, prescribing errors 
included errors in drug indications, drug–disease inter-
actions, drug–drug interactions (DDI) and dosing error, 
as well as inappropriate prescribing, which was the most 
common error reported.
Indication
Koper et al23 found that, on average, 2.7 medications per 
patient were not indicated, with a total of 94% of patients 
having medications prescribed by the general practi-
tioner (GP), but not mentioned in the indication of the 
UpToDate.23
Drug–disease interactions or contraindications
Drug–disease interactions were measured in one study by 
Mand et al33 with a prevalence of 10%.33
Drug–drug interactions
The prevalence of DDIs was measured in 11 studies and 
ranged from 2% to 58%.23 24 26 27 30 34–39 This could in part 
have been due to the fact that different DDI screening 
tools were used, namely DDI compendia and ePocrates 
RX, Thomson Micromedex program, Pharmavista data-
base, BotPlus program of the General Council of Pharma-
cists’ Official Colleges, British National Formulary 2010, 
Italian computerised interaction database, DrugDigest, 
Drugs, Micromedex and Medscape.
Inappropriate prescribing
A. The prevalence of potentially inappropriate medica-
tion (PIM) was measured in 37 studies in the elder-
ly age group only (≥65 years) and ranged from 5% 
to 94%.18 19 23 26 29 37 40–70 This extremely wide range 
of inappropriate prescribing prevalence estimates is 
likely to be, at least in part, due to the different detec-
tion tools used, namely Beers 2003, the 2006 Health 
Plan Employer Data and Information Set, improved 
prescribing in the elderly tool, Medication Appro-
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Person’s Prescriptions criteria. Johnell and Fastbom46 
and Haider et al mentioned two other specific crite-
ria.46 48
B. The prevalence of potential prescribing omission 
(PPO) was measured in five studies for the elder-
ly age group only (≥65 years), ranging from 23% to 
57%.19 51 65 66 69 PPO was detected by the Screening 
Tool to Alert doctors to Right Treatment and Assess-
ing Care of Vulnerable Elders.
Dosing errors
Koper et al23 found that overdosing and/or underdosing 
was found in 44% of patients.23
Monitoring errors
Monitoring errors were measured in one study by Ramia 
and Zeenny,71 who found that 73% of patients had incom-
plete therapeutic/safety laboratory-test monitoring 
tests.71
Other errors: discrepancy
One study found that at least one discrepancy between 
the medication lists from the pharmacy, the GP or the 
patient was present in 86.7% of patients.31 In another 
study, almost half of the patients (47.6%; 95% CI 40.5 to 
54.7) had one or more discrepancies in medication infor-
mation at discharge.32
The reported point or period prevalence of medica-
tion errors in the community settings, including self-re-
ported medication errors, prescribing errors (indication, 
drug–disease interaction, DDI, dosing error and inappro-
priate prescribing), monitoring error and discrepancies, 
had a very wide range from 2% to 94%. Figure 2 shows 
the medication errors prevalence estimates stratified 
according to the settings. The highest prevalence was in 
primary healthcare or general practice (94%).
rIsK fACtOrs
Risk factors for medication errors were either related to 
patients, healthcare professionals and/or medications.
Patient-related risk factors
Patient-related risk factors for the develop-
ment of medication errors were discussed in 33 
studies.18 20 27 29–33 37 38 40–43 48 49 51–53 55 57 58 60 62 64–67 69 70 73–75
Seven risk factors related to patients were addressed 
in the included studies: polypharmacy, increased age, 
number of diseases or comorbidities, female, low level of 
education, hospital admission and middle family income 
(table 3).
Several definitions of polypharmacy existed, ranging 
from prescription of at least three to six medications 
concurrently. Twenty-six studies showed a positive 
association between medication error and polyphar-
macy,18 27 29–33 37 38 40–42 49 51–53 55 57 58 64–67 69 70 74 of which 
18 mentioned the estimated OR ranging from 1.06 to 
11.45.18 27 29 30 32 33 37 38 40 42 49 52 57 64–67 69
Older age (≥75 years) was associ-
ated with medication errors in 13 
studies,18 27 33 38 40 48 49 51 57 65–67 69 of which 10 mentioned 
the OR ranging from 1.02 to 4.03.18 27 33 38 40 49 57 66 67 69
healthcare professional-related risk factors
Nine risk factors related to healthcare professionals 
for the development of medication errors were identi-
fied: more than one physician involved in their care, 
family medicine/GP specialty, age ≥51 years, male 
GP, frequent changes in prescription, not considering 
the prescription of other physicians, inconsistency 
in the information and outpatient clinic visits (see 
table 4).27 31 42 49 52 60 67 73 74
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Medication-related risk factors
Medication-related risk factors for the development of 
medication error were multiple medication storage loca-
tions used, expired medication present, discontinued 
medication repeats retained, hoarding of medications, 
therapeutic duplication,25 no medication administra-
tion routine, poor adherence and patients confused by 
generic and trade names.76 In one study by Johnell and 
Fastbom,46 multidose drug dispensing users (ie, medi-
cines machine-packed into unit-dose bags for each time 
of administration) were more exposed to all indicators of 
potentially inappropriate drug.46
Receiving anticoagulant therapy (OR 2.38, 95% CI 2.15 
to 2.64) was strongly associated in one study to potential 
drug–disease interactions.33
The use of OTC and/or prescribed drugs was a risk 
factor in two additional studies.29 43 The use of OTC medi-
cations was associated with PIM; the OR after adjusting for 
age, sex, education level, partnership, per capita income 
and occupation was 2.5 (95% CI 1.7 to 3.6) using Beers 
2003 and 1.8 (95% CI 1.2 to 2.5) using Beers 2012.29
errOr-relAteD ADverse events
Error-related adverse events or preventable ADEs were 
mentioned in six studies.22 28 29 31 32 77 The most frequently 
reported consequences were ED visits and hospitalisation.
Two methods for detecting ADE were applied: an ADE 
monitor (ie, using computerised programs composed of 
rules that identified incidents suggesting that an ADE 
might be present)22 and using trigger tools to detect 
ADEs.77
Incidence and/or prevalence
One study estimated preventable ADE incidence as 
15/1000 person-years.22 ACE inhibitors and beta-blockers 







OR or RR or beta (95% or 
99% CI) p values
Age ≥51 years 2 (53, 71) 2 NA OR 1.03 (95% CI 1.01 to 
1.06) p<0.0167
NA OR 1.238 (95% CI 1.235 to 
1.242) p<0.00149
More than one physician 
involved in their care
5 (22, 33, 64, 77, 
78)
3 NA Beta 0.7 (95% CI 0.5 to 1.0) 
p=0.03473
Adjusted for age, sex, 
number of chronic 
conditions and number 
or drug consumed
OR 1.39 (95% CI 1.17 to 
1.67) p<0.00127
Adjusted for age and 
number of prescriber
OR 3.52 (99% CI 3.44 to 3.60)60
Male general practitioner 2 (53, 71) 2 NA OR 1.07 (95% CI 1.05 to 
1.10) p<0.0167
NA OR 1.206 (95% CI 1.202 to 
1.210) p<0.00149
Frequent changes in prescription 1 (77) 1 NA Beta 0.4 (95% CI 0.2 to 0.9) 
p=0.01973
Not considering the prescription 
of other physicians
1 (77) 1 NA Beta 1.9 (95% CI 1.1 to 3.2) 
p=0.01373
Inconsistency in the information 1 (77) 1 NA Beta 4.4 (95% CI 1.3 to 14.8) 
p=0.01373
Outpatient clinic visit 1 (46) 1 NA 1.4 (male 95% CI 1.3 to 1.4) 
(female 95% CI 1.3 to 1.6)42
Family medicine/general practice 
specialty
3 (53, 56, 71) 3 NA OR 1.06 (95% CI 1.03 to 
1.10) p<0.0167
NA OR 1.267 (95% CI 1.265 to 
1.269) p<0.00149
NA OR 1.46 (95% CI 1.28 to 
1.65) p<0.0552
CCI, Charlson Comorbidity Index; IP, inappropriate prescribing; NA, not applicable; PIM, potentially inappropriate medication; PPO, potential 
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were the most common medications associated with 
preventable ADE.22 The estimate of the prevalence of 
preventable ADE was calculated from five studies as 
detailed below.28 29 31 32 77
All stages of medicines’ management process
Field et al found the prevalence of error caused by patients 
leading to an adverse event to be 0.38%, that is, less than 
1% of the overall population experienced a medica-
tion-related adverse event. They found that the majority 
of patient errors-related adverse events (n=129) occurred 
in modifying the medication regimen (42%), admin-
istering the medication (32%) or not following clinical 
advice about medication use (22%).77 The medications 
associated with more than 10 preventable ADEs were anti-
coagulants/antiplatelets, cardiovascular drugs, diuretics, 
hypoglycaemics and non-opioid analgesics.77




Obreli-Neto et al28 found that DDI-related adverse drug 
reaction (ADR) occurred in 7% of patients. Warfarin, 
digoxin, spironolactone and acetylsalicylic acid were 
the drugs most commonly associated with DDI-related 
ADRs.28
Potentially inappropriate medication
Forty-six per cent of participants reported complaints 
related to ADEs by interview; 95% of these were caused 
by prescribed medications.29
Use of inappropriate drugs was associated with an 
increased risk of nursing home admission, hospitalisa-
tion, more outpatient visit days, ED visits and having 
ADEs or ADRs.44 52 63 68
Other errors
Adverse events (undertreatment due to deletions, ADR 
due to additions and DDI) related to discrepancy between 
the medication lists from the patient, the GP or the phar-
macy were identified in 24% of patients.31 Two discrep-
ancies were categorised as having the potential to cause 
severe patient harm.32
rIsK fACtOrs
Risk factors for the error-related adverse events were 
discussed in three studies only.28 31 77
Patient-related risk factors
Field et al found that the number of regularly sched-
uled medications (seven or more medications) (OR 3.3, 
95% CI 1.5 to 7.0) and a Charlson Comorbidity Index 
(CCI) score of 5 or more (OR 15.0, 95% CI 6.5 to 34.5) 
were both associated with higher risk of patient error 
leading to preventable ADE.77 Obreli-Neto et al28 found 
that an age of 80 years or more (OR 4.4, 95 % CI 3.0 to 
6.1, p<0.01), a CCI of 4 or more (OR 1.3, 95% CI 1.1 to 
1.8, p<0.01) and consumption of five or more medications 
(OR 2.7, 95% CI 1.9 to 3.1, p<0.01) were associated with 
the occurrence of DDI-related ADRs. In addition, Tulner 
et al31 found that the number of medications was signifi-
cantly positively correlated with medication discrepancy 
adverse patient events.
Medication-related risk factors
The use of medication with narrow therapeutic indices 
such as warfarin was associated with an increased risk of 
DDI-related ADRs (OR 1.7, 95% CI 1.1 to 1.9, p<0.01).28
DIsCussIOn
summary of main findings
We sought to critically review previous studies conducted 
in the community of the incidence/prevalence of medi-
cation errors and associated adverse events and to identify 
the main risk factors. We identified 60 studies carried out in 
various countries providing a comprehensive assessment of 
the available evidence on the epidemiology of medication 
errors and error-related ADEs in community settings.
No relevant studies on the incidence of medication 
errors in these settings were found. The reported point 
or period prevalence of medication errors in community 
settings had a very wide range (ie, 2%–94%). This wide 
range appears, at least in part, to be due to the inconsis-
tency in the definitions of the medication errors used in 
the studies, differences in populations studied, methodol-
ogies employed for error detection and different outcome 
measures. More than half (37 studies) of the resulting 
studies were regarding the prescription of inappropriate 
drugs within the prescribing error stage in an elderly age 
group using different criteria. The comparison of those 
criteria is challenging due to the difference in medication 
use, consumption and availability of those medications to 
patients between countries. Further work is needed to 
review errors occurring at administration and dispensing 
stages of the medicines’ management process.
As for preventable ADEs, which may in some cases occur 
as a result of medication errors, only one study reported 
error-related adverse events incidence, measured as 
15/1000 person-years.22 The prevalence of preventable 
ADE was further reported in five other studies and varied 
according to the medication error type that resulted in 
the adverse event.
The most common patient-related risk factors for both 
medication errors and preventable ADEs mentioned 
were the number of medications used by the patient and 
the increased age of patients.
strengths and limitations
The main strength of this systematic review is that a 
rigorous and transparent process has been employed, 
which included no language restrictions, an indepen-
dent screening of titles and abstracts, independent data 
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two reviewers. It is the first review undertaken within 
community settings. The use of the ICPS conceptual 
framework,17 which provides a comprehensive defini-
tion of each concept and type of error in the medicines’ 
management process, is a further strength.
However, several limitations need to be considered. 
First, despite the thorough process, no data were found 
regarding the dispensing error stage. This might be due 
to the lack of a ‘dispensing error’ key term in our search 
strategy, although ‘medication therapy management’ as a 
key term was included. However, 10 studies on dispensing 
errors were excluded because they failed to satisfy the 
inclusion criteria on one or more counts. Second, no data 
were found regarding the administration error stage. 
However, 14 studies on administration errors were also 
excluded for the same previous reason. Third, this system-
atic review had different outcomes reported in a variety of 
ways using different tools and methodology, which made 
combining results in one meta-analysis difficult. Lastly, 
the studies addressed risk factors adjusted for different 
confounders, which makes it difficult to generate compa-
rable estimates and/or make causal inferences about 
whether the harm resulted from the medication error.
Comparison of the findings with previous studies
The definitional variation issue is supported by another 
two reviews.78 79 Other systematic reviews focusing on the 
safety of primary care contexts only have identified studies 
with vastly different prevalence estimates of the rates of 
medication errors. These reflect differences in definitions, 
sampling strategy and populations studied; none have 
investigated the risk factors for medication errors.80 81
Implications for research, policy and practice
There is a need for (1) improvement in the quality of 
research in this area—it is important that all researchers 
provide a standardised set of outcome measures of medi-
cation errors or internationally accepted terminology 
and definitions of key concepts; (2) training and moni-
toring of healthcare professionals with the involvement 
of medication safety pharmacists in the community; (3) 
empowering and educating the patients and the public, 
particularly those with chronic diseases and polyphar-
macy, to increase their knowledge of medication safety 
with a record of the current medication list for each 
patient; (4) patient use of tools and technology particu-
larly for monitoring and follow-up; and (5) encourage the 
reporting of medication errors, administration errors and 
dispensing errors.82 This would strengthen the quality of 
research, improve the development of strategies to detect 
and prevent these errors, and provide a safer environ-
ment for the community to self-care safely.
COnClusIOns
We found a very wide variation in the medication error and 
error-related adverse events rate between studies, which, 
at least in part, reflects differences in their definitions, 
methodologies employed for error detection or clinical 
heterogeneity, that is, differences in populations studied 
and different outcome measures. Most of the studies were 
conducted on elderly populations in economically devel-
oped countries. There is therefore clearly a need to extend 
this work to low-income and middle-income countries, 
particularly give the WHO’s recent launch of a Global 
Medication Safety Challenge.82 83 Furthermore, most 
studies focused only on inappropriate prescribing with 
relatively little attention to other stages such as admin-
istration and dispensing. The most common patient and 
medication-related risk factors for both medication errors 
and preventable ADEs were the number of medications 
used by the patient, increased age and receiving anticoag-
ulant therapy. The most common healthcare profession-
al-related risk factor for medication error was when more 
than one practitioner was involved in the care of patients 
and care provision by family medicine and GP specialities.
This study has identified important limitations and 
discrepancies in the methodology used to study medica-
tion errors and error-related ADEs in community settings. 
These findings need to be considered in the context of 
designing future research related to medication safety. 
More research is needed in the areas of incidence of 
medication errors, administration error and dispensing 
errors and reporting. Researchers should use a more 
consistent set of definitions and outcomes in order to 
facilitate collation and synthesis of data.
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